Join the mRNA Vaccine Race With Affinity Purification 

mRNA Vaccine race
Thermo logo

mRNA Vaccine race

mRNA based interventions are becoming much more prevalent in current times, with several leading SARS-CoV-2 vaccines relying on mRNA technology. Bench-scale mRNA purification methods cannot keep up with large-scale production of clinical-grade mRNA and consequently developers are looking to adopt faster, more efficient, highly scalable methods for purification.

Download this whitepaper to learn about an affinity-based method that can:

  • Streamline the production of mRNA vaccines
  • Be readily adopted for biotherapeutic development